1. Home
  2. HTHT vs BBIO Comparison

HTHT vs BBIO Comparison

Compare HTHT & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTHT
  • BBIO
  • Stock Information
  • Founded
  • HTHT 2005
  • BBIO 2015
  • Country
  • HTHT China
  • BBIO United States
  • Employees
  • HTHT N/A
  • BBIO N/A
  • Industry
  • HTHT Hotels/Resorts
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTHT Consumer Discretionary
  • BBIO Health Care
  • Exchange
  • HTHT Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • HTHT 10.2B
  • BBIO 9.4B
  • IPO Year
  • HTHT 2010
  • BBIO 2019
  • Fundamental
  • Price
  • HTHT $37.60
  • BBIO $53.38
  • Analyst Decision
  • HTHT Strong Buy
  • BBIO Strong Buy
  • Analyst Count
  • HTHT 2
  • BBIO 16
  • Target Price
  • HTHT $45.00
  • BBIO $63.81
  • AVG Volume (30 Days)
  • HTHT 2.4M
  • BBIO 2.3M
  • Earning Date
  • HTHT 08-20-2025
  • BBIO 08-05-2025
  • Dividend Yield
  • HTHT 5.17%
  • BBIO N/A
  • EPS Growth
  • HTHT 1.05
  • BBIO N/A
  • EPS
  • HTHT 1.66
  • BBIO N/A
  • Revenue
  • HTHT $3,390,100,226.00
  • BBIO $235,812,000.00
  • Revenue This Year
  • HTHT $6.35
  • BBIO $115.49
  • Revenue Next Year
  • HTHT $6.88
  • BBIO $64.61
  • P/E Ratio
  • HTHT $21.87
  • BBIO N/A
  • Revenue Growth
  • HTHT 4.24
  • BBIO 7.62
  • 52 Week Low
  • HTHT $28.27
  • BBIO $21.72
  • 52 Week High
  • HTHT $42.98
  • BBIO $53.97
  • Technical
  • Relative Strength Index (RSI)
  • HTHT 68.34
  • BBIO 63.37
  • Support Level
  • HTHT $36.03
  • BBIO $49.75
  • Resistance Level
  • HTHT $37.58
  • BBIO $52.85
  • Average True Range (ATR)
  • HTHT 0.84
  • BBIO 2.12
  • MACD
  • HTHT 0.22
  • BBIO 0.18
  • Stochastic Oscillator
  • HTHT 95.54
  • BBIO 91.76

About HTHT H World Group Limited

H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, managed, and franchised models. The company has two operating segments: legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: